Charcot Joints: A Case Study

D, Dr Munde D. D Dr Munde D.; Karne, S L; Shah, Nakul S

doi:10.15373/2249555x/jan2013/48

Cited by 2 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Charcot osteoarthropathy is a destructive disorder of bones and joints secondary to neurosensory deficit that produces progressive degeneration of the joint, marked by bony destruction and resorption eventually leading to deformity. 1 …”

Section: Discussionmentioning

confidence: 99%

A Rare Charcot Neuro-Osteoarthropathy of Hip with an Uncommon Cause

Vijay

Geethapriya

Govindaraj

et al. 2022

Indian J Radiol Imaging

View full text Add to dashboard Cite

Neuro-osteoarthropathy often called as Charcot joint results from decreased sensory innervations of the involved joint resulting in severely damaged and disrupted joints and involvement of adjacent soft tissues. Charcot joint is characterized by the “6Ds,” which are i) distended joints, ii) density increase, iii) debris production, iv) dislocation, v) disorganization, and vi) destruction. Hip joint involvement is very rare probably because of rich nerve supply compared with other peripheral joints. To minimize the joint deformity and loss of function, early diagnosis is of great importance in which radiological imaging plays a major role.

show abstract

Section: Discussionmentioning

confidence: 99%

A Rare Charcot Neuro-Osteoarthropathy of Hip with an Uncommon Cause

Vijay

Geethapriya

Govindaraj

et al. 2022

Indian J Radiol Imaging

View full text Add to dashboard Cite

show abstract

Charcot Neuro-Osteoarthropathy With Superimposed Osteomyelitis in a Nondiabetic Patient, as a Consequence of Cancer Chemotherapy: A MR-Monitored Case Report

Giangreco,

Iacopi,

Maltinti

et al. 2024

The International Journal of Lower Extremity Wounds

View full text Add to dashboard Cite

Charcot neuro-osteoarthropathy (CNO) is a manifestation of peripheral neuropathy as a chronic complication of diabetes mellitus but, less frequently, can be associated to other conditions such as alcoholism or neurotoxic therapies. An increasingly emerging cause of CNO is the use of oncological drugs which can cause neuropathic damage. The use of these therapies dramatically increased in recent years. CNO leads to a progressive degeneration of the foot's joints and to bone destruction and resorption which ends in deformities. These alterations in the foot's anatomy determine a high risk of ulceration, infection, and osteomyelitis. The superimposition of osteomyelitis on CNO increases the risk of major amputation, already high in patients suffering either from only CNO or osteomyelitis alone. We report the case of a 61-year old nondiabetic woman affected by CNO as a consequence of antiblastic therapy for breast cancer and the subsequent overlap of osteomyelitis, confirmed by magnetic resonance imaging. This case underlines how it is necessary to consider CNO as a possible complication of antiblastic therapy in the view of the severe consequences of missing its diagnosis.

show abstract

Charcot Joints: A Case Study

Cited by 2 publications

References 3 publications

A Rare Charcot Neuro-Osteoarthropathy of Hip with an Uncommon Cause

A Rare Charcot Neuro-Osteoarthropathy of Hip with an Uncommon Cause

Charcot Neuro-Osteoarthropathy With Superimposed Osteomyelitis in a Nondiabetic Patient, as a Consequence of Cancer Chemotherapy: A MR-Monitored Case Report

Contact Info

Product

Resources

About